Clinical Trials · NCT03089073

Study of Minirin Melt® in Adult Patients With Nocturia

Phase
N/A
Recruitment status
Terminated
Sponsor
Ferring Pharmaceuticals
Enrollment
835
Start date
Jul 2015
Locations
1 site, South Korea
Primary endpoint
Change from baseline in mean number of nocturnal voids
View Desmopressin compound reference